The vitamin D receptor mediates the signal of 1 a,25-dihydroxyvitamin D 3 by binding to vitamin D responsive elements in DNA as a homodimer or as a heterodimer composed of one vitamin D receptor subunit and one retlnold X receptor subunlt. We have mapped the dimerization interfaces of the vitamin D receptor that is involved In homo-or heterodimer formation in the absence of DNA. While deletion of the first zinc finger region of vitamin D receptor diminished homodlmerization activity, it did not affect heterodimerization. In contrast, a deletion just beyond the zinc finger region affected heterodlmerization with retinoid X receptor, but not homodimerization. The zinc finger region alone could form a homodimer with full-length vitamin D receptor, but not a heterodimer with retinoid X receptor. The carboxy-terminal region was also necessary for heterodimer formation. This region showed only a weak dimerization activity in the absence of llgand, but this was dramatically increased in the presence of llgand for both homo-and heterodlmerization. These results suggest that the vitamin D receptor has at least three dimerization interfaces whose functions are apparently distinguishable. These are located in the first zinc finger region, the region just beyond this zinc finger and in the carboxyterminal region.
INTRODUCTION
The vitamin D receptor (VDR) is a member of the steroid/thyroid hormone receptor superfamily that functions as a dimeric molecule in nuclei to regulate the transcription level of target genes in a ligand-dependent manner (1) (2) (3) (4) . All members of this superfamily contain a highly conserved region called a zinc finger, that is indispensable for specific binding to target DNA sequences termed hormone responsive elements (HRE) (5) (6) (7) (8) (9) (10) . Members of the receptor superfamily bind DNA as homodimers or as heterodimers in conjunction with other members of the family A subset of these nuclear receptors, including VDR, thyroid hormone receptor (TR) and retinoic acid receptor (RAR), each preferentially bind to a direct repeat of the HRE half-site motif as a heterodimer that contains the common co-regulator, retinoid X receptor (RXR) (11, 12) . The DNA binding specificity of these receptors is in part determined by differential spacing between the core recognition motif half-site HREs (13) . In contrast to these receptors, steroid hormone receptors such as glucocorticoid receptor (GR) and estrogen receptor (ER) bind to the palindromic sequences of the same HRE half-site motif as homodimers. Since these receptor/DNA complexes are symmetric, it is assumed that the dimerization interfaces of the receptor subunits on a single half-site are in close contact with each other which readily facilitates protein-protein interactions. This model was confirmed by three-dimensional structural analysis of crystals of the GR DNA binding domain/DNA complex (14) However, the shape of heterodimers on the direct repeat should be asymmetric and the dimenzation interfaces of the heterodimenc subunits of these receptors might be expected to be different from those of the homodimeric steroid receptors.
Towers et al. and we reported previously that the VDR DNA binding domain (VDRDBD) could bind to the vitamin D responsive element (VDRE) derived from the mouse osteopontin (mSPPl) gene, but not VDREs derived from the osteocalcin (OST) and the calbindin D-9K (CaBP) genes (15, 16) . The mSPPl VDRE contains a direct repeat of GGTTCA motif separated by three nucleotides, whereas the OST and CaBP VDREs have imperfect direct repeats. For binding to the imperfect direct repeat, the heterodimenzation of VDR with RXR is essential (17) . In addition, it has been reported that the signal of la,25-dihydroxyvitamin D 3 [ 1, 25(OH>2D3] is mediated by homodimer or heterodimer apparently by different mechanisms (18) The dimerization interface of VDR is therefore of great interest, since it appears to be involved in two types of dimerizations. In this paper, we analyzed the dimerization interfaces of the VDR and found that these are different for homoand heterodimer formation.
Protein-protein interactions are important for communication of activators with general transcriptional factors The transactivators are thought to modulate transcription by promoting or stabilizing the assembly of preinitiation complexes including TFIID through protein-protein interactions (19) . Direct interactions between several activators and general transcription factors such as TBP or TFTIB have been reported (20, 21) . In some cases, coactivators, also termed bridging factors or adapters, may mediate the signals of transactivators to the general transcriptional machinery, for example the CBP/P300 family (22, 23) . The nuclear hormone receptors work in a ligand-dependent manner. The conformational change by ligand binding might allow them to communicate with the general factors. We propose the ligand-inducible dimenzation as a candidate for this conformational change.
MATERIALS AND METHODS

Construction of VDR mutants and expression vectors
Expression vectors encoding rat VDR (24) and the deletion mutants were constructed as follows Ohgonucleotide primers flanking selected regions of the VDR cDNA were synthesized with a Sma\ and a EcoRl restriction sites upstream and downstream of the desired coding sequence, respectively. The polymerase chain reaction (PCR) was used to synthesize fragments of the intervening DNA. These PCR fragments were cloned into the bacterial expression vector pMAL-c2 (New England Biolabs) at in-frame Xmnl-EcoRl site of the vector's malE gene. The inserted sequences were confirmed by the dideoxy method. The constructs were subsequently transformed into Escherichia coli JM109, and VDR proteins including various deletion mutants were produced as described below.
In vitro transcription and translation reactions
Rat VDR (24) and RXRp (11) cDNA clones for in vitro transcription were inserted into pBluescnpt under control of the T7 RNA polymerase promoter. In vitro transcription reactions were performed as described by the manufacturer (Pharmacia). 35 S-Methionine labeled proteins were synthesized by in vitro translation in rabbit reticulocyte lysates following the manufacturer's instructions (Promega). The products were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and shown to be of appropriate sizes (data not shown).
Protein-binding assays using MBP fusion protein
Because the truncated DNA fragments of VDR were inserted downstream from the malE gene encoding maltose-binding protein (MBP), the VDR mutants were expressed in the form of fusion protein with MBP. The MBP fusion proteins were expressed by IPTG induction, and adsorbed to amylose resin columns (New England Biolabs) which exhibit high affinity for MBP (16) . Approximately 50 (il of amylose resin containing various MBP-VDR fusion proteins, obtained from a series of deletion mutants, was incubated at 4°C in 0.1 ml of buffer containing 50 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, 10% glycerol, 2.5 mM dithiothreitol and 50 nM ZnCl 2 (TEGDZ). Ten uJ of 35 S-methionine labeled VDR or RXRP was added, and binding was allowed to proceed for 1 h at 4°C. The resin was washed three times with TEGDZ buffer, and bound proteins were eluted with 50 (il of the same buffer containing 50 mM maltose and resolved by electrophoresis. 35 S-Methionine labeled proteins retained on VDR-amylose resin were visualized by autoradiography. For the experiment of ligand effect on protein-protein interaction, VDR was preincubated with 1,25(OH)2D3 (Duphar) at 4°C in TEGDZ buffer overnight and then mixed with 
1,25(OH) 2 D 3 binding assay
Ligand binding activity was determined by hydroxylapatite binding assay (25) using 1,25(OH>2D3 [26,27- 3 H]D 3 (New England Nuclear) and nonradioactive 1,25(OH)2D3 (Duphar).
RESULTS
Dunerization activity of VDR in solution
The dimerization activity of VDR was investigated by the MBP based protein-protein binding assay. The MBP-VDR fusion protein adsorbed to amylose resin was incubated with 35 S-methionine labeled VDR or RXRp. 35 S-labeled receptors bound to MBP-VDR were eluted from the resin, resolved by SDS-PAGE and analyzed by autoradiography (Fig. la) . By this system, we can assay the dimerization activity of VDR in the absence of DNA. As shown in Figure 1 b, the full-length VDR could form not only the heterodimer with RXRp (lane 2), but also the homodimer (lane 4). About 5% of input radioactivity was recovered by these assays for both types of dimerization. Control experiments using MBP instead of MBP-VDR were also shown (lane 1 or 3). Although it was previously shown that the RXR-VDR heterodimer was more stable than the VDR homodimer in the presence of VDRE (26, 27) , the dimerization activities of homo-and heterodimer revealed the same level where assessed by the protein-protein interactions method used here. This result suggested that dimerization modes with and without DNA were somehow different. When 35 S-labeled RXR and 35 S-labeled VDR were simultaneously put into the MBP-VDR adsorbed amylose resin, the bands corresponding to RXR and VDR appeared almost in the same intensity (data not shown).
Dimerization interfaces of zinc finger region
A series of deletion mutants of VDR protein, which were overexpressed in E.coli as fusion proteins with MBP, were adsorbed to amylose resin and used to map the domain responsible for the dimer formation. We first examined the effect of deletion of zinc finger region on dimerization. As shown in Figure 2a , the deletion of the first zinc finger diminished the homodimerization activity (lane 6), whereas it had no effect on the heterodimer formation with RXR (lanes 1-3) . On the contrary, the deletion just after zinc finger region diminished remarkably the heterodimerization activity (Fig. 2b, lanes 1-3) , but this had no effect on homodimerization (Fig. 2b, lanes 4-6) . However, the dimerization activity did not completely disappear in both cases. When we examined whether the VDRDBD (amino acids 1-123) alone was able to form a dimer or not, this fragment could dimerize with the 35 S-VDR at the same level as the case of the full-length VDR, but not with 35 S-RXR (compare Fig. 4b , lane 7 with Fig. 4c, lane 7) . Moreover, we have previously reported that the VDRDBD alone can bind to the mSPPl VDRE as a homodimer (16) . These results demonstrate that the VDR zinc finger region is sufficient for homodimerization, but the C-terminal region is indispensable for heterodimerization with RXR.
Dimerization interfaces of C-terminal region
It has been reported that the C-terminal ligand-binding domain of the RAR is important for dimer formation with RXR (11). Therefore, we next examined the effect of C-terminal deletion on the VDR-RXR interaction. In order to exclude the effect of the first zinc finger dimerization interface, we used the deletion constructs of the first zinc finger region. The VDRs7^23 showed activity comparable to full-length VDR in heterodimer formation (Fig. 2a, lanes 1 and 3) . As shown in Figure 3, C-terminal 21 amino acids of VDR reduced heterodimerization activity somewhat, and further deletion (to amino acid 359) completely abolished the VDR-RXR interaction. That is to say, the C-terminal region was also essential for the heterodimerization and two regions, proximate after zinc finger and C-terminal, worked cooperatively. These results demonstrate that the mechanism of homodimer formation is different from that for heterodimer formation.
Effect of ligand on dimerization activity
Because the VDR is a ligand-inducible transcription activator, we next examined the effect of ligand on the dimerization activity.
Prior to the dimerization experiments, we determined the precise location of ligand binding domain (Fig. 4a) . The deletion of C-terminal 21 amino acids completely diminished the ligand binding activity. Regarding the N-terminus, the region following the 124th amino acid was required for a detectable level of ligand binding activity. Based on this result, we chose to examine some VDR deletion mutants for effects of ligand binding on dimerization activity. As shown in Figure 4 , both homo-and heterodimerization activities, especially in VDR] 24-423. were enhanced by the addition of 1,25(OH)2D3, (compare lane 5 with 6 in Fig.  4b or c) . However, the increase of dimerization in full-length VDR was small (Fig. 4b and c, lanes 1 and 2) . The reason for this may be due to the co-existence of constitutive dimerization interfaces located in the N-terminal region (Figs 2 or 5a) . In other words, the initial activity of full-length VDR was too high to detect the ligand dependency. In the case of VDR124-423. because the other interface was removed, the ligand dependency could be clearly observed. As a control, when we examined the VDR)_i24 which did not have ligand binding ability, the ligand-dependent increases of dimerization were not observed ( Fig. 4b and c, lanes  7 and 8) . It was reported that for the steroid hormone receptor ligand-induced homodimer formation was necessary in order to bind DNA (28) . However, our results showed that the liganddependent dimerization occurred even in the absence of DNA.
DISCUSSION
By using the MBP based protein-protein binding assay, we have elucidated the dimerization interfaces of VDR involved in homo-or heterodimer formation. The VDR has at least three distinct dimerization interfaces which are functionally different from each other. The critical regions whose deletion dramatically decreased the dimerization activity were compared with other nuclear receptors and aligned in Figure 5 Region A corresponded to the zinc finger which was known to have dimerization interface (29, 30) . Region B was found to contain the T-box (31) and region C contained the ninth heptad repeat (32) . Region C also corresponded to a potential dimenzation interface which was identified in ER (33) and RXRa (34) . The dimenzation interface in the first zinc finger region is involved in homodimerization, while regions beyond the zinc finger and a discrete C-terminal region are required for heterodimenzation, and the C-terminal region works independently for both types of dimer formation in a ligand-dependent manner (Fig. 5a) . The presence of multiple dimenzation interfaces may explain the difference of transactivation through VDR homo-and heterodimers (18) . An inverted palindrome functions as a response element for the VDR homodimer, whereas a direct repeat element is preferentially mediated by the RXR-VDR heterodimer (18) . Probably, the RXR-VDR heterodimer placement on the direct repeat is rotationally different from a homodimer on an inverted palindrome. The presumed difference in polarity of DNA binding exhibited by homo-and heterodimers may be explained by the fact that the homodimer requires only one dimerization surface and the heterodimer utilizes two surfaces.
The C-terminal regions of nuclear hormone receptors has been proven to contain partially overlapping functions, i.e. ligand binding, dimerization and transactivation (32) (33) (34) , and each of these functions could be discriminated by point mutations (35) .
In this paper, we demonstrated that both edges of C-terminal region of VDR were critical for the ligand binding activity (Fig.  4) . As shown in Figure 3 , the deletion mutant VDR57^to2 retained dimenzation activity, although this construct completely abolished ligand binding activity. This fact suggests that the dimerization interface of C-terminus exists within the ligand binding domain or overlapping consistent with previous reports (32) (33) (34) (35) . So far, the ligand function related to the transactivation has not been known. In this paper, we desenbed that the dimerization activity of C-terminal region was dramatically affected by ligand. We think that this phenomenon may possibly relate to ligand mediated transactivation.
Recently, Cheskis et al. reported on the dimerization of VDR in the presence of DNA. In that paper, they described that the VDR was a monomer in solution and dimerized in a DNA dependent manner (26) . Certainly, the affinity of VDR for RXR or VDR is very weak in solution and therefore most VDR molecules should exist as monomers in the absence of DNA. However, we succeeded to detect such weak dimerization activity by using MBP-VDR fusion protein and 35 S-labeled receptors. The advantage of this system is that it has the ability to detect dimerization activity of mutants which lack DNA binding, and consequently we were able to map the dimerization interfaces.
Nuclear hormone receptors have several dimerization interfaces which lie in distinct locations (28) (29) (30) 33, 36, 37) . Although most of these interfaces had been studied in connection with DNA binding, such assay systems might not distinguish the dimerization interface required for DNA binding from that required for transactivation. We propose that the ligand-dependent dimerization through the C-terminal region may be important for ligand-dependent transactivation of VDR. We are now looking for a co-activator which can discnminate the hgand-mediated dimer form from the hgand-free VDR.
